DMD and Duchenne muscular dystrophy: Regarding potential treatment for DMD, there is growing evidence that the antisense oligonucleotides (ASOs)-mediated exon skipping approach can restore functional dystrophin proteins and improve muscle function, by restoring the open reading frame around the site of dystrophin mutations [20–22].